Liquid chromatographic assay and pharmacokinetics of halazepam and its metabolite in humans.
暂无分享,去创建一个
[1] E. Radwanski,et al. Multiple‐dose halazepam kinetics , 1984, Clinical pharmacology and therapeutics.
[2] D. Greenblatt,et al. Clinical Pharmacokinetics of the Newer Benzodiazepines , 1983, Clinical pharmacokinetics.
[3] W. E. Fann,et al. Pharmacology, Efficacy, and Adverse Effects of Halazepam, A New Benzodiazepine , 1982, Pharmacotherapy.
[4] J S Harmatz,et al. Diazepam disposition determinants , 1980, Clinical pharmacology and therapeutics.
[5] D. Greenblatt,et al. Single‐Dose Kinetics of Prazepam, a Precursor of Desmethyldiazepam , 1979, Journal of clinical pharmacology.
[6] R. Kellner,et al. The Effects of One‐Day Treatment of Anxiety with High Doses of Halazepam , 1978, Journal of clinical pharmacology.
[7] R. Kershner,et al. Effect of antacids on absorption of clorazepate , 1977, Clinical pharmacology and therapeutics.
[8] U. Klotz,et al. Disposition of diazepam and its major metabolite desmethyldiazepam in patients with liver disease , 1977 .
[9] D. Hoffman,et al. Steady‐State Bioavailability of Two Clorazepate Dipotassium Dosage Forms , 1977, Journal of clinical pharmacology.
[10] G. Tognoni,et al. Pharmacokinetics of N-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline. , 1975, British journal of clinical pharmacology.
[11] Fan We,et al. Halazepam in anxious outpatients: a controlled study. , 1974 .
[12] C M Metzler,et al. Bioavailability--a problem in equivalence. , 1974, Biometrics.
[13] D. Greenblatt,et al. Benzodiazepines in Clinical Practice , 1974 .
[14] K. Alexander,et al. Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. , 1973, Journal of pharmaceutical sciences.
[15] G. Biscaldi,et al. Quantitative polygraphic evaluation of emotional tension in the study of a new benzodiazepine. , 1971, Current therapeutic research, clinical and experimental.